cited_by cdi_FETCH-LOGICAL-c2140-ca7e1fa86285e75e4b19e1ab1ea0e454a0bc8e24f9f30c0ea56ca0d5a3a6f3e43
cites cdi_FETCH-LOGICAL-c2140-ca7e1fa86285e75e4b19e1ab1ea0e454a0bc8e24f9f30c0ea56ca0d5a3a6f3e43
container_end_page 745
container_issue 3
container_start_page 734
container_title Neuropsychopharmacology (New York, N.Y.)
container_volume 37
creator QUEIROZ HOEXTER, Marcelo
DE SOUZA DURAN, Fabio Luis
MIGUEL, Euripedes Constantino
BUSATTO, Geraldo
CHAUBET D'ALCANTE, Carina
DOUGHERTY, Darin Dean
GEDANKE SHAVITT, Roseli
LOPES, Antonio Carlos
BELO DINIZ, Juliana
DECKERSBACH, Thilo
BATISTUZZO, Marcelo Camargo
BRESSAN, Rodrigo Affonseca
description
doi_str_mv 10.1038/npp.2011.250
format article
fullrecord <record><control><sourceid>pascalfrancis_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1038_npp_2011_250</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>25643637</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2140-ca7e1fa86285e75e4b19e1ab1ea0e454a0bc8e24f9f30c0ea56ca0d5a3a6f3e43</originalsourceid><addsrcrecordid>eNo9kMFOwzAMhiMEEmNw4wFy4UZH0jRtx20rbCANTUID7Va5mcOC2qZKuonxCrw0rYY42bL-z7I_Qq45G3Em0ru6aUYh43wUSnZCBjyJWBCLaH1KBiwdi4ALsT4nF95_MsZlEqcD8jN3cKAv0Lbo6LstdxV6amq6LDx6b_YYZLZqdmXf0gfjrdt0wSlq65BCvaET3ZOzcme_sDU1UutoZj9q0_bwFLewN91otUUHzeGeTuhrh9nKfOOGZqWpjYKSrpyB8pKcaSg9Xv3VIXmbPa6yp2CxnD9nk0WgQt59pCBBriGNw1RiIjEq-Bg5FByBYSQjYIVKMYz0WAumGIKMFbCNBAGxFhiJIbk97lXOeu9Q540zFbhDzlnei8w7kXkvMu9EdvGbY7wB392qHdTK-H8mlHEkYpGIX-xudqU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial</title><source>PubMed Central</source><creator>QUEIROZ HOEXTER, Marcelo ; DE SOUZA DURAN, Fabio Luis ; MIGUEL, Euripedes Constantino ; BUSATTO, Geraldo ; CHAUBET D'ALCANTE, Carina ; DOUGHERTY, Darin Dean ; GEDANKE SHAVITT, Roseli ; LOPES, Antonio Carlos ; BELO DINIZ, Juliana ; DECKERSBACH, Thilo ; BATISTUZZO, Marcelo Camargo ; BRESSAN, Rodrigo Affonseca</creator><creatorcontrib>QUEIROZ HOEXTER, Marcelo ; DE SOUZA DURAN, Fabio Luis ; MIGUEL, Euripedes Constantino ; BUSATTO, Geraldo ; CHAUBET D'ALCANTE, Carina ; DOUGHERTY, Darin Dean ; GEDANKE SHAVITT, Roseli ; LOPES, Antonio Carlos ; BELO DINIZ, Juliana ; DECKERSBACH, Thilo ; BATISTUZZO, Marcelo Camargo ; BRESSAN, Rodrigo Affonseca</creatorcontrib><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1038/npp.2011.250</identifier><identifier>CODEN: NEROEW</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Adult and adolescent clinical studies ; Anxiety disorders. Neuroses ; Behavior therapy. Cognitive therapy ; Biological and medical sciences ; Medical sciences ; Neuropharmacology ; Obsessive-compulsive disorders ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychopharmacology ; Treatments</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2011-10, Vol.37 (3), p.734-745</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2140-ca7e1fa86285e75e4b19e1ab1ea0e454a0bc8e24f9f30c0ea56ca0d5a3a6f3e43</citedby><cites>FETCH-LOGICAL-c2140-ca7e1fa86285e75e4b19e1ab1ea0e454a0bc8e24f9f30c0ea56ca0d5a3a6f3e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25643637$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>QUEIROZ HOEXTER, Marcelo</creatorcontrib><creatorcontrib>DE SOUZA DURAN, Fabio Luis</creatorcontrib><creatorcontrib>MIGUEL, Euripedes Constantino</creatorcontrib><creatorcontrib>BUSATTO, Geraldo</creatorcontrib><creatorcontrib>CHAUBET D'ALCANTE, Carina</creatorcontrib><creatorcontrib>DOUGHERTY, Darin Dean</creatorcontrib><creatorcontrib>GEDANKE SHAVITT, Roseli</creatorcontrib><creatorcontrib>LOPES, Antonio Carlos</creatorcontrib><creatorcontrib>BELO DINIZ, Juliana</creatorcontrib><creatorcontrib>DECKERSBACH, Thilo</creatorcontrib><creatorcontrib>BATISTUZZO, Marcelo Camargo</creatorcontrib><creatorcontrib>BRESSAN, Rodrigo Affonseca</creatorcontrib><title>Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial</title><title>Neuropsychopharmacology (New York, N.Y.)</title><subject>Adult and adolescent clinical studies</subject><subject>Anxiety disorders. Neuroses</subject><subject>Behavior therapy. Cognitive therapy</subject><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Obsessive-compulsive disorders</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Treatments</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNo9kMFOwzAMhiMEEmNw4wFy4UZH0jRtx20rbCANTUID7Va5mcOC2qZKuonxCrw0rYY42bL-z7I_Qq45G3Em0ru6aUYh43wUSnZCBjyJWBCLaH1KBiwdi4ALsT4nF95_MsZlEqcD8jN3cKAv0Lbo6LstdxV6amq6LDx6b_YYZLZqdmXf0gfjrdt0wSlq65BCvaET3ZOzcme_sDU1UutoZj9q0_bwFLewN91otUUHzeGeTuhrh9nKfOOGZqWpjYKSrpyB8pKcaSg9Xv3VIXmbPa6yp2CxnD9nk0WgQt59pCBBriGNw1RiIjEq-Bg5FByBYSQjYIVKMYz0WAumGIKMFbCNBAGxFhiJIbk97lXOeu9Q540zFbhDzlnei8w7kXkvMu9EdvGbY7wB392qHdTK-H8mlHEkYpGIX-xudqU</recordid><startdate>20111026</startdate><enddate>20111026</enddate><creator>QUEIROZ HOEXTER, Marcelo</creator><creator>DE SOUZA DURAN, Fabio Luis</creator><creator>MIGUEL, Euripedes Constantino</creator><creator>BUSATTO, Geraldo</creator><creator>CHAUBET D'ALCANTE, Carina</creator><creator>DOUGHERTY, Darin Dean</creator><creator>GEDANKE SHAVITT, Roseli</creator><creator>LOPES, Antonio Carlos</creator><creator>BELO DINIZ, Juliana</creator><creator>DECKERSBACH, Thilo</creator><creator>BATISTUZZO, Marcelo Camargo</creator><creator>BRESSAN, Rodrigo Affonseca</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20111026</creationdate><title>Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial</title><author>QUEIROZ HOEXTER, Marcelo ; DE SOUZA DURAN, Fabio Luis ; MIGUEL, Euripedes Constantino ; BUSATTO, Geraldo ; CHAUBET D'ALCANTE, Carina ; DOUGHERTY, Darin Dean ; GEDANKE SHAVITT, Roseli ; LOPES, Antonio Carlos ; BELO DINIZ, Juliana ; DECKERSBACH, Thilo ; BATISTUZZO, Marcelo Camargo ; BRESSAN, Rodrigo Affonseca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2140-ca7e1fa86285e75e4b19e1ab1ea0e454a0bc8e24f9f30c0ea56ca0d5a3a6f3e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Anxiety disorders. Neuroses</topic><topic>Behavior therapy. Cognitive therapy</topic><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Obsessive-compulsive disorders</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>QUEIROZ HOEXTER, Marcelo</creatorcontrib><creatorcontrib>DE SOUZA DURAN, Fabio Luis</creatorcontrib><creatorcontrib>MIGUEL, Euripedes Constantino</creatorcontrib><creatorcontrib>BUSATTO, Geraldo</creatorcontrib><creatorcontrib>CHAUBET D'ALCANTE, Carina</creatorcontrib><creatorcontrib>DOUGHERTY, Darin Dean</creatorcontrib><creatorcontrib>GEDANKE SHAVITT, Roseli</creatorcontrib><creatorcontrib>LOPES, Antonio Carlos</creatorcontrib><creatorcontrib>BELO DINIZ, Juliana</creatorcontrib><creatorcontrib>DECKERSBACH, Thilo</creatorcontrib><creatorcontrib>BATISTUZZO, Marcelo Camargo</creatorcontrib><creatorcontrib>BRESSAN, Rodrigo Affonseca</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>QUEIROZ HOEXTER, Marcelo</au><au>DE SOUZA DURAN, Fabio Luis</au><au>MIGUEL, Euripedes Constantino</au><au>BUSATTO, Geraldo</au><au>CHAUBET D'ALCANTE, Carina</au><au>DOUGHERTY, Darin Dean</au><au>GEDANKE SHAVITT, Roseli</au><au>LOPES, Antonio Carlos</au><au>BELO DINIZ, Juliana</au><au>DECKERSBACH, Thilo</au><au>BATISTUZZO, Marcelo Camargo</au><au>BRESSAN, Rodrigo Affonseca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><date>2011-10-26</date><risdate>2011</risdate><volume>37</volume><issue>3</issue><spage>734</spage><epage>745</epage><pages>734-745</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><coden>NEROEW</coden><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><doi>10.1038/npp.2011.250</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-133X
ispartof Neuropsychopharmacology (New York, N.Y.), 2011-10, Vol.37 (3), p.734-745
issn 0893-133X
1740-634X
language eng
recordid cdi_crossref_primary_10_1038_npp_2011_250
source PubMed Central
subjects Adult and adolescent clinical studies
Anxiety disorders. Neuroses
Behavior therapy. Cognitive therapy
Biological and medical sciences
Medical sciences
Neuropharmacology
Obsessive-compulsive disorders
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychopharmacology
Treatments
title Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T12%3A49%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gray%20Matter%20Volumes%20in%20Obsessive-Compulsive%20Disorder%20Before%20and%20After%20Fluoxetine%20or%20Cognitive-Behavior%20Therapy:%20A%20Randomized%20Clinical%20Trial&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=QUEIROZ%20HOEXTER,%20Marcelo&rft.date=2011-10-26&rft.volume=37&rft.issue=3&rft.spage=734&rft.epage=745&rft.pages=734-745&rft.issn=0893-133X&rft.eissn=1740-634X&rft.coden=NEROEW&rft_id=info:doi/10.1038/npp.2011.250&rft_dat=%3Cpascalfrancis_cross%3E25643637%3C/pascalfrancis_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2140-ca7e1fa86285e75e4b19e1ab1ea0e454a0bc8e24f9f30c0ea56ca0d5a3a6f3e43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true